Latest Insider Transactions at Hanover Bancorp, Inc. (HNVR)
This section provides a real-time view of insider transactions for Hanover Bancorp, Inc. (HNVR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hanover Bancorp, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hanover Bancorp, Inc. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Robert Golden Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+6.42%
|
-
|
|
Mar 01
2024
|
Elena Sisti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+2.08%
|
-
|
|
Mar 01
2024
|
Michael David M.D. Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+1.42%
|
-
|
|
Mar 01
2024
|
Ahron H Haspel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+8.56%
|
-
|
|
Mar 01
2024
|
John R Sorrenti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+4.56%
|
-
|
|
Feb 20
2024
|
Lance P Burke EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,040
-2.38%
|
$17,680
$17.6 P/Share
|
|
Feb 20
2024
|
Mc Clelland W Wilcox President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,974
-1.78%
|
$50,558
$17.6 P/Share
|
|
Feb 20
2024
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-2.79%
|
$7,276
$17.6 P/Share
|
|
Jan 31
2024
|
Robert Golden Director |
BUY
Open market or private purchase
|
Direct |
500
+1.71%
|
$9,000
$18.0 P/Share
|
|
Jan 29
2024
|
Elena Sisti Director |
BUY
Open market or private purchase
|
Direct |
2,750
+2.74%
|
$49,500
$18.01 P/Share
|
|
Jan 29
2024
|
Michael David M.D. Katz Director |
BUY
Open market or private purchase
|
Direct |
700
+0.48%
|
$12,600
$18.02 P/Share
|
|
Jan 19
2024
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.13%
|
-
|
|
Jan 19
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+11.32%
|
-
|
|
Jan 19
2024
|
Mc Clelland W Wilcox President |
BUY
Grant, award, or other acquisition
|
Direct |
7,745
+8.44%
|
-
|
|
Jan 19
2024
|
Kevin Corbett EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+10.63%
|
-
|
|
Jan 19
2024
|
Michael P Puorro Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,300
+3.92%
|
-
|
|
Dec 26
2023
|
Mc Clelland W Wilcox President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,783
-19.75%
|
$319,311
$17.4 P/Share
|
|
Dec 26
2023
|
Mc Clelland W Wilcox President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,900
+23.92%
|
$119,600
$4.46 P/Share
|
|
Dec 08
2023
|
Philip A Okun Director |
SELL
Open market or private sale
|
Direct |
1,124
-3.36%
|
$19,108
$17.75 P/Share
|
|
Dec 06
2023
|
John R Sorrenti Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+7.66%
|
$35,000
$10.0 P/Share
|
|
Dec 01
2023
|
Joseph F Burns EVP & Chief Lending Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Dec 01
2023
|
John P Vivona FSVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+50.0%
|
-
|
|
Nov 08
2023
|
Elena Sisti Director |
BUY
Open market or private purchase
|
Direct |
265
+0.28%
|
$4,770
$18.0 P/Share
|
|
Feb 20
2023
|
Mc Clelland W Wilcox President |
SELL
Payment of exercise price or tax liability
|
Direct |
842
-1.28%
|
$15,998
$19.56 P/Share
|
|
Feb 20
2023
|
Alice T Rouse EVP & Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
833
-3.13%
|
$15,827
$19.56 P/Share
|
|
Feb 20
2023
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-2.9%
|
$8,132
$19.56 P/Share
|
|
Jan 24
2023
|
Elena Sisti Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+1.67%
|
-
|
|
Jan 24
2023
|
John R Sorrenti Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+4.0%
|
-
|
|
Jan 24
2023
|
Philip A Okun Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+4.6%
|
-
|
|
Jan 24
2023
|
Metin Negrin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+0.69%
|
-
|
|
Jan 24
2023
|
Michael David M.D. Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+1.1%
|
-
|
|
Jan 24
2023
|
Ahron H Haspel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+7.29%
|
-
|
|
Jan 24
2023
|
Varkey Abraham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+4.13%
|
-
|
|
Jan 24
2023
|
Alice T Rouse EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,153
+7.48%
|
-
|
|
Jan 24
2023
|
Kevin Corbett EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,380
+10.26%
|
-
|
|
Jan 24
2023
|
Robert Golden Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,612
+5.4%
|
-
|
|
Jan 24
2023
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,267
+10.56%
|
-
|
|
Jan 24
2023
|
Michael P Puorro Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,445
+3.43%
|
-
|
|
Jan 24
2023
|
Mc Clelland W Wilcox President |
BUY
Grant, award, or other acquisition
|
Direct |
6,612
+9.1%
|
-
|
|
Dec 01
2022
|
John R Sorrenti Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,557
+8.76%
|
$35,570
$10.0 P/Share
|
|
Aug 12
2022
|
Michael David M.D. Katz Director |
BUY
Open market or private purchase
|
Indirect |
40
+38.1%
|
$800
$20.11 P/Share
|
|
Aug 11
2022
|
Michael David M.D. Katz Director |
BUY
Open market or private purchase
|
Indirect |
25
+50.0%
|
$475
$19.99 P/Share
|
|
Aug 11
2022
|
Elena Sisti Director |
BUY
Other acquisition or disposition
|
Direct |
3,384
+2.29%
|
-
|
|
May 11
2022
|
Michael P Puorro Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+1.91%
|
$105,000
$21.0 P/Share
|
|
May 11
2022
|
Varkey Abraham Director |
BUY
Open market or private purchase
|
Direct |
2,500
+4.84%
|
$52,500
$21.0 P/Share
|
|
May 11
2022
|
Robert Golden Director |
BUY
Open market or private purchase
|
Direct |
5,000
+7.78%
|
$105,000
$21.0 P/Share
|
|
May 11
2022
|
Ahron H Haspel Director |
BUY
Open market or private purchase
|
Direct |
5,000
+20.93%
|
$105,000
$21.0 P/Share
|
|
May 11
2022
|
Michael David M.D. Katz Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.38%
|
$105,000
$21.0 P/Share
|
|
May 11
2022
|
Metin Negrin Director |
BUY
Open market or private purchase
|
Direct |
8,000
+3.33%
|
$168,000
$21.0 P/Share
|
|
May 11
2022
|
Philip A Okun Director |
BUY
Open market or private purchase
|
Direct |
3,000
+8.61%
|
$63,000
$21.0 P/Share
|